Medium Dose of Cytarabine and Mitoxantrone (HAM)

Southern University of Science and Technology

Status: Unknown

Conditions: Acute Myelogenous Leukemia; Chemotherapy

Treatments: Drug: Mitoxantrone; Device: Flow Cytometer; Drug: Cytarabine

Study type: Observational

Funder types: Other

Identifiers

NCT04024241

YLi

Details and patient eligibility

About

By observation of the inpatients in shenzhen people's hospital,research the curative effect of the two chemotherapy schemes on AML-High dose of cytarabine and HAM.

Full description

The patients of AML in shenzhen people's hospital were randomly divided into two therapy groups.One group was treated by High dose of cytarabine ,and the other was HAM.Evaluate the two chemotherapy schemes by bone marrow suppression time and patient survival time.

Enrollment: 250 estimated patients

Sex: All

Ages: 14 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

people diagnosed as AML

Exclusion criteria

• acute promyeloytic leukemia

Trial design

250 participants in 2 patient groups

high dose of cytarabine

Description:

high dose of cytarabine

Treatment:

Device: Flow Cytometer

Drug: Cytarabine

Drug: Mitoxantrone

HAM

Description:

medium dose of cytarabine and mitoxantrone

Treatment:

Device: Flow Cytometer

Drug: Cytarabine

Drug: Mitoxantrone